1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 17 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlersMcVernon, J.; Nolan, T.; Richmond, P.; Reynolds, G.; Nissen, M.; Lambert, S.; Marshall, H.; Papa, T.; Rehm, C.
2015Febrile seizures following measles and varicella vaccines in young children in AustraliaMacartney, K.; Gidding, H.; Trinh, L.; Wang, H.; McRae, J.; Crawford, N.; Gold, M.; Kynaston, A.; Blyth, C.; Yvonne, Z.; Elliott, E.; Booy, R.; Buttery, J.; Marshall, H.; Nissen, M.; Richmond, P.; McInytre, P.; Wood, N.
2010Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trialNolan, T.; McVernon, J.; Skeljo, M.; Richmond, P.; Wadia, U.; Lambert, S.; Nissen, M.; Marshall, H.; Booy, R.; Heron, L.; Hartel, G.; Lai, M.; Basser, R.; Gittleson, C.; Greenberg, M.
2015Five-year antibody persistence and safety after a single dose of combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in Haemophilus influenzae Type B-primed toddlersBooy, R.; Nolan, T.; Reynolds, G.; Richmond, P.; Nissen, M.; Marshall, H.; Stoney, T.; Van Der Wielen, M.; Kolhe, D.; Miller, J.
2013Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescentsLambert, S.; Chuk, L.; Nissen, M.; Nolan, T.; McVernon, J.; Booy, R.; Heron, L.; Richmond, P.; Walls, T.; Marshall, H.; Reynolds, G.; Hartel, G.; Hu, W.; Lai, M.
2015Group A streptococcal carriage and seroepidemiology in children up to 10 years of age in AustraliaMarshall, H.; Richmond, P.; Nissen, M.; Lambert, S.; Booy, R.; Reynolds, G.; Sebastian, S.; Pride, M.; Jansen, K.; Anderson, A.; Scully, I.
2011Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of ageBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Heron, L.; Lambert, S.; Caubet, M.; Mesaros, N.; Boutriau, D.
2013Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in hib-primed toddlersBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Stoney, T.; Heron, L.; Lambert, S.; Mesaros, N.; Peddiraju, K.; Miller, J.
2013A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescentsNissen, M.; Marshall, H.; Richmond, P.; Jiang, Q.; Harris, S.; Jones, T.; Jansen, K.; Perez, J.
2013A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adultsMarshall, H.; Richmond, P.; Nissen, M.; Wouters, A.; Baber, J.; Jiang, Q.; Anderson, A.; Jones, T.; Harris, S.; Jansen, K.; Perez, J.

Discover